Dupixent
DupixentAbout
Dupixent (dupilumab) is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL4) and interleukin-13 (IL13) pathways. It is used to treat a range of allergic and inflammatory diseases, including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, chronic spontaneous urticaria, bullous pemphigoid, and chronic obstructive pulmonary disease. The drug has received approvals in various age groups, from infants to adults, and is administered via subcutaneous injection.
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Dupixent do?
Dupixent (dupilumab) is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL4) and interleukin-13 (IL13) pathways. It is used to treat a range of allergic and inflammatory diseases, including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, chronic spontaneous urticaria, bullous pemphigoid, and chronic obstructive pulmonary disease. The drug has received approvals in various age groups, from infant…
What industry does Dupixent operate in?
Dupixent operates in HealthTech, AI Infrastructure, AI Tools, Generative AI, Foundation Model, API Platform.